Mohammad Daud Ali
Impact in
- Toxicology top 5%
- Pharmacovigilance and Adverse Drug Reactions
- Law top 1%
- Legal Studies and Policies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 5
- Pharmacology 10
- Co-authors
- Ayaz Ahmad (18 shared papers)Arun Kumar (7 shared papers)Ranjit Kumar (8 shared papers)Md Ali Mujtaba (5 shared papers)Pintoo Kumar Niraj (3 shared papers)Ashok Ghosh (5 shared papers)R. Hassan (1 shared paper)M.S.I. Dhami (1 shared paper)
- Journals
- Journal of Young Pharmacists (6 papers)Saudi Pharmaceutical Journal (2 papers)International Journal of Pharmaceutical Investigation (2 papers)Saudi Journal of Biological Sciences (1 paper)Cancers (1 paper)
- Partner nations
- Saudi ArabiaIndiaPakistan
In The Last Decade
Mohammad Daud Ali
80 papers receiving 639 citations
Peers
Comparison fields: 5 of 134
- Toxicology 54
- Law 129
- Accounting 148
- Geriatrics and Gerontology 31
- Complementary and alternative medicine 65
Countries citing papers authored by Mohammad Daud Ali
This map shows the geographic impact of Mohammad Daud Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Daud Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Daud Ali more than expected).
Fields of papers citing papers by Mohammad Daud Ali
This network shows the impact of papers produced by Mohammad Daud Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Daud Ali. The network helps show where Mohammad Daud Ali may publish in the future.
Co-authors
The 25 scholars most cited alongside Mohammad Daud Ali, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 98 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Sistem ekonomi islam zakat dan wakaf | 1988 | 203 |
| 2 | 1991 | 43 | |
| 3 | Phytoremedial effect of Withania somnifera against arsenic-induced testicular toxicity in Charles Foster rats. | 2015 | 38 |
| 4 | Lembaga-lembaga Islam di Indonesia | 1995 | 36 |
| 5 | 2021 | 34 | |
| 6 | 2017 | 34 | |
| 7 | 2019 | 32 | |
| 8 | 2020 | 28 | |
| 9 | 2019 | 25 | |
| 10 | 2019 | 20 | |
| 11 | 2020 | 20 | |
| 12 | 2021 | 14 | |
| 13 | 2021 | 14 | |
| 14 | 2022 | 13 | |
| 15 | Hukum Islam dan peradilan agama (Kumpulan tulisan) | 2002 | 11 |
| 16 | 2024 | 9 | |
| 17 | 2019 | 9 | |
| 18 | 2022 | 7 | |
| 19 | 2021 | 7 | |
| 20 | 2019 | 7 |
About Mohammad Daud Ali
Mohammad Daud Ali is a scholar working on Infectious Diseases, Pharmacology, Epidemiology, Complementary and alternative medicine and Sociology and Political Science, having authored 98 papers that have together received 749 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (7 papers), Phytochemicals and Medicinal Plants (6 papers), Legal Studies and Policies (6 papers), Pharmaceutical Practices and Patient Outcomes (5 papers), Heavy Metal Exposure and Toxicity (5 papers), Pneumonia and Respiratory Infections (5 papers), Computational Drug Discovery Methods (5 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). The work is most often cited by research in Toxicology (54 citations), Law (129 citations), Accounting (148 citations), Geriatrics and Gerontology (31 citations) and Complementary and alternative medicine (65 citations). Mohammad Daud Ali has collaborated with scholars based in Saudi Arabia, India and Pakistan. Frequent co-authors include Ayaz Ahmad, Arun Kumar, Ranjit Kumar, Md Ali Mujtaba, Pintoo Kumar Niraj, Ashok Ghosh, R. Hassan, M.S.I. Dhami, Mohammed Afzal and Afzal Hussain. Their work appears in journals such as Journal of Young Pharmacists, Saudi Pharmaceutical Journal, International Journal of Pharmaceutical Investigation, Saudi Journal of Biological Sciences and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.